Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of 0.41% is 247% above its 4-year average of -0.28%, near the high end of its 4-year range (-79.86%–10.62%).
786.48% above its 12-month average of 0.05%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): 2.18%.
OPERATING MARGIN
0.41%
OPERATING MARGIN AVG TTM
0.05%
OPERATING MARGIN AVG 3Y
-1.61%
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+786.48%
CURRENT VS 3Y AVG
+125.46%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
13.52%
median of 100 covered companies
CURRENT VS SECTOR MEDIAN
-96.97%
vs the sector median at left
Fortrea Holdings Inc.
Market Cap
$1.90B
Operating Margin
0.41%
TTM Avg
0.05%
3Y Avg
-1.61%
5Y Avg
N/A
Market Cap
$1.74B
Operating Margin
11.69%
TTM Avg
-8.16%
3Y Avg
-10.59%
5Y Avg
-4.68%
Market Cap
$1.71B
Operating Margin
-651.67%
TTM Avg
-787.38%
3Y Avg
-968.58%
5Y Avg
-820.03%
Market Cap
$2.16B
Operating Margin
-867.87%
TTM Avg
-840.98%
3Y Avg
-774.76%
5Y Avg
-1234.34%
Market Cap
$2.52B
Operating Margin
-274.57%
TTM Avg
-464.41%
3Y Avg
-382.79%
5Y Avg
-92575.80%
Market Cap
$2.76B
Operating Margin
12.21%
TTM Avg
13.21%
3Y Avg
-4.78%
5Y Avg
-42.05%
Market Cap
$1.00B
Operating Margin
-6.98%
TTM Avg
-25.06%
3Y Avg
-156.73%
5Y Avg
-114.38%
Market Cap
$474.59M
Operating Margin
-8.63%
TTM Avg
-11.52%
3Y Avg
-18.04%
5Y Avg
-16.64%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | $1.90B | 0.41% | 0.05% | -1.61% | N/A |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.74B | 11.69% | -8.16% | -10.59% | -4.68% |
| Intellia Therapeutics, Inc. (NTLA)vs › | $1.71B | -651.67% | -787.38% | -968.58% | -820.03% |
| Recursion Pharmaceuticals, Inc. (RXRX)vs › | $2.16B | -867.87% | -840.98% | -774.76% | -1234.34% |
| Beam Therapeutics Inc. (BEAM)vs › | $2.52B | -274.57% | -464.41% | -382.79% | -92575.80% |
| TransMedics Group, Inc. (TMDX)vs › | $2.76B | 12.21% | 13.21% | -4.78% | -42.05% |
| Teladoc Health, Inc. (TDOC)vs › | $1.00B | -6.98% | -25.06% | -156.73% | -114.38% |
| NeoGenomics, Inc. (NEO)vs › | $474.59M | -8.63% | -11.52% | -18.04% | -16.64% |
| NRC Health (NRC)vs › | $458.62M | 10.53% | 20.52% | 24.67% | 27.45% |
| Shoulder Innovations, Inc. (SI)vs › | $394.23M | -58.53% | -50.96% | -52.76% | -52.76% |
Gross Margin
17.1%
Operating Margin
0.4%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 2.18% |
| 2026-03-31 | 0.52% |
| 2025-12-31 | 1.33% |
| 2025-09-30 | -2.27% |
| 2025-06-30 | -1.53% |
| 2025-03-31 | -79.86% |
| 2024-12-31 | -7.98% |
| 2024-09-30 | -2.67% |
| 2024-06-30 | -7.68% |
| 2024-03-31 | -5.65% |
| 2023-12-31 | -1.38% |
| 2023-09-30 | 1.44% |
| 2023-06-30 | 4.36% |
| 2023-03-31 | 2.03% |
| 2022-12-31 | -1.65% |
| 2022-09-30 | 9.04% |
| 2022-06-30 | 10.62% |
| 2022-03-31 | 5.43% |
